Shares of Agios Pharmaceuticals jumped nearly 16% on Wednesday ⁠after the U.S. Food and Drug Administration approved the expanded use of it...

The Environment Ministry of India will participate in a significant climate conference at Harvard University, organized by the South Asia I...

The US Food and Drug Administration (FDA) has approved two gene therapies for sickle cell disease, including the first treatment in the US ...

As we prepare to commemorate Thalassaemia Awareness Day this year and promote greater understanding of this disease, here are some key poin...

The pill technically called hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor can be given to both patients who are on dialysi...

In the complaint submitted at the IP Estate Police Station, the apex medical body said Ramdev has "wilfully and deliberately spread false, ...

Ramdev went on to ask if allopathy had medicines for fatty liver and liver cirrhosis. "Like you found a cure for TB and chicken pox, look f...

As per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term ...

Currently only two drugs, metformin and insulin, are approved for the treatment of diabetes in children.

The symptoms aggravate due to dehydration, infection and hypoxia.

Anaemia commonly arises in kidney disease patients, because the kidneys no longer produce sufficient amounts of erythropoietin, a hormone w...

Of the patients in the study population, 43 per cent were men; average age was 50 years.

Around 3.4% of the global population are carriers of thalassaemia.

The scientists gave infected red blood cells an unusual amino acid and used luminol's glow to trigger the chemical, killing the parasite.

Mukilesh's dream of becoming a pilot came true early this week when IAF 'readily accepted' a wish placed in this regard by a local NGO.

The Prime Minister, on the second day of his Japan tour, raised the issue during his visit to the Stem Cell Research facility.

Actorise is a biosimilar of 'Darbepoetin alfa', which is marketed by US-based Amgen under the brand Aranesp.